Valiant Laboratories Limited (VALIANTLAB.NS)
INR 95.51
(2.06%)
INR 95.51
(2.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.05 Billion INR | -5.91% |
| 2022 | 1.12 Billion INR | 1.92% |
| 2021 | 1.1 Billion INR | 522.33% |
| 2020 | 177.32 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.05 Billion INR | 0.0% |
| 2023 FY | 1.05 Billion INR | -5.91% |
| 2023 Q2 | 1.09 Billion INR | -4.97% |
| 2023 Q1 | 1.15 Billion INR | 2.55% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 1.12 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hester Biosciences Limited | 3.59 Billion INR | 70.561% |
| Albert David Limited | 1.15 Billion INR | 7.986% |
| Alembic Limited | 1.43 Billion INR | 26.104% |
| Alkem Laboratories Limited | 48.6 Billion INR | 97.823% |
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | 93.497% |
| Bafna Pharmaceuticals Limited | 652.27 Million INR | -62.241% |
| Bajaj HealthCare Limited | 4.86 Billion INR | 78.259% |
| FDC Limited | 3.7 Billion INR | 71.469% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | 79.574% |
| Gufic Biosciences Limited | 5.59 Billion INR | 81.102% |
| Hikal Limited | 12.99 Billion INR | 91.856% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | 53.777% |
| Ind-Swift Limited | 13.45 Billion INR | 92.134% |
| Innova Captab Limited | 4.89 Billion INR | 78.402% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -256.605% |
| Jubilant Pharmova Limited | 61.27 Billion INR | 98.273% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -64.356% |
| Laurus Labs Limited | 42.71 Billion INR | 97.522% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | 1.515% |
| Lupin Limited | 96.23 Billion INR | 98.9% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | 46.453% |
| Medico Remedies Limited | 438.24 Million INR | -141.478% |
| Morepen Laboratories Limited | 4.45 Billion INR | 76.271% |
| Nectar Lifesciences Limited | 11.21 Billion INR | 90.566% |
| Orchid Pharma Limited | 3.84 Billion INR | 72.47% |
| Procter & Gamble Health Limited | 2.56 Billion INR | 58.681% |
| RPG Life Sciences Limited | 1.38 Billion INR | 23.326% |
| Solara Active Pharma Sciences Limited | 14.09 Billion INR | 92.49% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 99.424% |
| Suven Pharmaceuticals Limited | 2.03 Billion INR | 47.977% |
| Themis Medicare Limited | 1.88 Billion INR | 43.934% |
| Unichem Laboratories Limited | 8.06 Billion INR | 86.885% |
| Vaishali Pharma Limited | 371.16 Million INR | -185.12% |
| Venus Remedies Limited | 1.39 Billion INR | 24.019% |
| Wanbury Limited | 3.15 Billion INR | 66.463% |
| Windlas Biotech Limited | 1.76 Billion INR | 39.964% |
| ZIM Laboratories Limited | 2.08 Billion INR | 49.141% |
| Ipca Laboratories Limited | 33.74 Billion INR | 96.864% |
| Aarti Drugs Limited | 11.5 Billion INR | 90.801% |
| Aarti Pharmalabs Limited | 8.25 Billion INR | 87.174% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -266.435% |
| Brooks Laboratories Limited | 248.6 Million INR | -325.687% |
| Eris Lifesciences Limited | 38.26 Billion INR | 97.235% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | 83.279% |
| Sigachi Industries Limited | 2.53 Billion INR | 58.192% |
| Sakar Healthcare Limited | 1.26 Billion INR | 16.229% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 99.305% |
| Divi's Laboratories Limited | 18.99 Billion INR | 94.427% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | 71.095% |
| Mankind Pharma Limited | 23.87 Billion INR | 95.567% |
| Sequent Scientific Limited | 8.27 Billion INR | 87.21% |
| Neuland Laboratories Limited | 5.49 Billion INR | 80.754% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | 90.117% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 98.375% |
| Zydus Lifesciences Limited | 71.79 Billion INR | 98.526% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -35.013% |
| Wockhardt Limited | 39.87 Billion INR | 97.346% |
| Bal Pharma Limited | 2.51 Billion INR | 57.86% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 99.011% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | 49.818% |
| Par Drugs and Chemicals Limited | 159.79 Million INR | -562.278% |
| Caplin Point Laboratories Limited | 3.5 Billion INR | 69.812% |
| Shilpa Medicare Limited | 12.93 Billion INR | 91.817% |
| Ajanta Pharma Limited | 10.71 Billion INR | 90.119% |
| Aarey Drugs & Pharmaceuticals Limited | 1.72 Billion INR | 38.551% |
| Granules India Limited | 22.95 Billion INR | 95.39% |
| Medicamen Biotech Limited | 940.36 Million INR | -12.537% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | 9.179% |
| Piramal Enterprises Limited | 560.47 Billion INR | 99.811% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 98.71% |
| NATCO Pharma Limited | 10.53 Billion INR | 89.952% |
| Suven Life Sciences Limited | 148.62 Million INR | -612.053% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | 64.415% |
| Strides Pharma Science Limited | 37.68 Billion INR | 97.191% |
| Indoco Remedies Limited | 10.34 Billion INR | 89.768% |
| Alpa Laboratories Limited | 307.12 Million INR | -244.573% |
| Lasa Supergenerics Limited | 541.92 Million INR | -95.278% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | 72.816% |